TKT and glioblastoma: Ahmad et al. found that costunolide significantly retarded the pentose phosphate pathway in A172 and U87 glioblastoma cells and reduced the expression of its two main enzymes, glucose-6-phosphate dehydrogenase (G6PD) and transketolase (TKT) [51].